The Psychedelic Drugs Market report emphasizes current and future market trends and carries out analysis of the effect of buyers, substitutes, new entrants, competitors, and suppliers on the market. This market report gives estimations on the market status, growth rate, future trends, market drivers, opportunities, challenges, entry barriers, risks, sales channels, and distributors. The key research methodology that has been employed here by DBMR research team is data triangulation which entails data mining, analysis of the impact of data variables on the market & primary (industry expert) validation. The global Psychedelic Drugs Market report has all the company profiles of the major market players and brands.
Get Exclusive Sample Copy of This Report Here https://www.databridgemarketresearch.com/request-a-sample?dbmr=global-psychedelic-drugs-market
Global psychedelic drugs market is rising gradually with a healthy CAGR in the forecast periPsychedelic Drugs Marketod of 2019-2026. Growing prevalence of depression worldwide and increase in special designation from the regulatory authorities to the company to expedite the development process are the key factors for market growth.
Few of the major competitors currently working in the global psychedelic drugs market are COMPASS, The Emmes Company, LLC, Klarisana, AstraZeneca, F. Hoffmann-La Roche Ltd, Dr. Reddy’s Laboratories Ltd, Takeda Pharmaceutical Company Limited, Pfizer Inc, Mylan N.V. , Merck & Co., Inc, Alkermes, ALLERGAN, H. Lundbeck A/S among others.
Read Complete Details with TOC Here https://www.databridgemarketresearch.com/toc?dbmr=global-psychedelic-drugs-market
Report Highlights:
- Shifting Industry dynamics
- In-depth Psychedelic Drugs Market segmentation
- Historical, current and projected industry size Recent industry trends
- Key Competition landscape
- Strategies for key players and product offerings
- Potential and niche segments/regions exhibiting promising growth
- A neutral perspective towards market performance
Market Definition: Global Psychedelic Drugs Market
Psychedelic drugs are also known as psychedelics are the class of hallucinogenic drugs including both classic hallucinogens as well as dissociative drugs that are used recreationally, to alter and enhance the sensory perception, elevate the mood swings, thought process, energy level promoting spiritual experiences. Psychedelic drugs have been used experimentally for psychological treatment and are able to control mind hence maintaining peace.
According to the statistic published in our World in Data 2017, the global burden of mental and substance use disorders were 122.76 million. Increase cases of mental disorders and accelerating demand of novel therapies are the drivers promoting the growth of this market.
Segmentation: Global Psychedelic Drugs Market
Psychedelic Drugs Market : By Application
- Major Depressive Disorder
- Resistant depression
- Panic disorder
- Post-traumatic stress disorder
- Opiate Addiction
- Others
Psychedelic Drugs Market : By Drugs
- Lysergic Acid Diethylamide (LSD)
- 3,4-MethylEnedioxyMethamphetamine (Ecstasy)
- Phencyclidine
- Gamma Hydroxybutyric Acid (GHB)
- Ketamine
- Ayahuasca
- Salvia
- Psilocybin
- Others
Psychedelic Drugs Market : By Route of Administration
- Oral
- Injectable
- Inhalation
Psychedelic Drugs Market : By Distribution Channel
- Direct Retailers
- Online Pharmacies
- Others
Psychedelic Drugs Market : By End-Users
- Hospitals
- Homecare
- Specialty Clinics
- Others
Psychedelic Drugs Market : By Geography
- North America
- South America
- Europe
- Asia-Pacific
- Middle East & Africa
Key Developments in the Psychedelic Drugs Market:
- In October 2018, COMPASS received Breakthrough Therapy designation from the FDA for psilocybin therapy for the treatment of resistant depression. With Breakthrough Therapy designation, company can obtain all fast track designation features and FDA commitment and guidance ensuring efficient drug development programme
- In August 2018, COMPASS received new drug application approval from the FDA for the psilocybin therapy for the treatment of resistant depression. If the trial is successful, it will change the treatment landscape of patients suffering from resistant depression
Key benefits of buying the Psychedelic Drugs Market Report:
This Psychedelic Drugs Market report will enable both of the sides in market be an established firm or a relative new entrant. It helps the established firms to know about the moves which are being performed by their competitors and also helps the new entrants by educating them about the market situations and the industry trends. This Psychedelic Drugs Market report is quite fruitful in helping to understand the market definition and all the aspects of the market including the CAGR value and key profiles.
To Get This Report at an Attractive Cost, Click Here https://www.databridgemarketresearch.com/speak-to-analyst?dbmr=global-psychedelic-drugs-market
About Data Bridge Market Research:
Data Bridge Market Research is a versatile market research and consulting firm with over 500 analysts working in different industries. We have catered more than 40% of the fortune 500 companies globally and have a network of more than 5000+ clientele around the globe. Our coverage of industries include Medical Devices, Pharmaceuticals, Biotechnology, Semiconductors, Machinery, Information and Communication Technology, Automobiles and Automotive, Chemical and Material, Packaging, Food and Beverages, Cosmetics, Specialty Chemicals, Fast Moving Consumer Goods, Robotics, among many others.
Data Bridge adepts in creating satisfied clients who reckon upon our services and rely on our hard work with certitude.We are content with our glorious 99.9 % client satisfying rate.
Contact Us
Data Bridge Market Research
US: +1 888 387 2818
UK: +44 208 089 1725
Hong Kong: +852 8192 7475
Mail: [email protected]
